Indian business news
Tuesday, May 26, 2020
Biocon Subsidiary Receives Nod To Use Cytosorb In Covid-19 Treatment
The licence will be effective until the COVID-19 outbreak is controlled in the country, the company said in a regulatory filing.
from NDTV Profit - Latest https://ift.tt/2M3KuBA
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment